Evidence mapPaperPMID 42429876Full record

ArticleSaudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society2026

Influence without medical expertise: a social network analysis of Mounjaro discussions on twitter (X).

Saja AlHazmi, Hayam A AlRasheed, Basma Gomaa

Abstract read
In one paragraph

Article in Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Saja AlHazmiDepartment of Sociobehavioral and Administrative Pharmacy, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, 33328, USA.ORCID http://orcid.org/0009-0006-6093-1677
Hayam A AlRasheedDepartment of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, P.O. Box 84428, 11671, Riyadh, Saudi Arabia.ORCID http://orcid.org/0009-0002-6186-848X
Basma GomaaDepartment of Sociobehavioral and Administrative Pharmacy, Barry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL, 33328, USA. bgomaa@nova.edu.ORCID http://orcid.org/0000-0003-4059-1143

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mounjaro (tirzepatide) is a recently approved medication for type 2 diabetes that is increasingly used off-label for weight loss, in part due to extensive promotion on social media. X has emerged as a major venue for discussions about weight-loss medications, yet limited research has examined public discourse surrounding Mounjaro. Identifying key influencers and mapping conversation dynamics are critical for understanding how social media may shape public awareness and adoption of emerging pharmacotherapies. This study examined Mounjaro-related discourse on X to identify influential information sources, dominant discussion topics, and public sentiment. A quantitative, exploratory observational design was employed using social network analysis and automated sentiment analysis of publicly available tweets. The dataset included 5,566 tweets generated by 5,641 unique users collected between January 9 and February 24, 2025. Using NodeXL, betweenness and in-degree centrality measures were used to identify influential users and content sources, and cluster analysis identified dominant discussion topics within the network. Sentiment analysis assessed the overall tone of Mounjaro-related tweets. Results indicated that the most influential users were predominantly non-medical individuals, including public figures and patients sharing personal experiences. Overall sentiment toward Mounjaro was largely positive, with 62.6% of tweets expressing favorable attitudes. Network clusters centered on weight loss, comparisons with Ozempic and Wegovy, pharmaceutical branding, and diabetes treatment. These findings highlight the prominent role of non-expert voices in shaping online discourse and underscore the need for evidence-based health communication strategies on social media.

Indexed as

MounjaroPublic perceptionsSentiment analysisSocial network analysisTirzepatideX

Identifiers

PMID42429876
PMCPMC13354737

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.